Instructions to Authors

About the Supplement

The European Heart Journal Supplement – the Heart of the Matter (EHJS) is an international peer-reviewed supplements journal of the European Society of Cardiology (ESC). It is a long-standing member of the ESC Journal Family that serves as a publication medium for supplemental issues of the flagship European Heart Journal.

EHJS publishes a broad range of articles from symposia to special issues on specific topics of interest. It offers a dedicated scientific space for the ESC, Institutions, National and Affiliate Societies, Associations, Working Groups and Councils to disseminate their important successes globally. All content in the supplements is invited and direct submissions are not considered.

Have an idea for a supplement?

If you are considering publishing a supplement, or have a proposal for a supplement, please contact Corporate Services.

Instructions to authors

Quick links:

Editorial policies
Preparing your manuscript
How to submit
Production of your manuscript
Contact us

Editorial policies

Publication Ethics and Malpractice Statement
Authorship
Contributors
Disclosure of Interest
Misconduct
Informed Patient Consent
Ethics
Reporting Demographic Information for Study Participants
Statistics
Data Policy
Data Citation
Peer Review Policy
Appealing a Decision
Preprints and self-archiving

Publication Ethics and Malpractice Statement

European Heart Journal Supplements and Oxford University Press are members of the Committee on Publication Ethics (COPE), and follow the guidance provided in the COPE Core Practices. The Supplement also subscribes to the International Committee of Medical Journal Editors (ICJME) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly work in Medical Journals. It is expected that all parties involved in the publication of content in the Supplement (the publisher, editors, authors, and peer reviewers) follow these guidelines on best practice and publication ethics. The Supplement is committed to investigating cases of alleged editor, author, and reviewer misconduct arising from its activities, and will follow COPE Guidelines in all cases.

The Editors are further supported by the ESC Publication Ethics Committee.

Authorship 

All individuals listed as authors should qualify for authorship and should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Each author included in the manuscript must meet ALL of the following conditions, as specified in the guidelines of the International Committee of Medical Journal Editors (ICJME). To qualify as an author, the individual must have

• Made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
• Drafted the work or reviewed it critically for important intellectual content; AND
• Given final approval of the version to be published; AND
• Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All individuals who meet the authorship criteria listed above should be listed as authors. Individuals who do not meet the above authorship criteria should not be listed as authors. The Supplement considers all forms of ghost authorship, in which an individual contributes in the role of an author (according to the criteria above) but is not listed as an author on the manuscript, and all forms of guest or gift authorship, in which individuals are included though they do not meet the above criteria, as unethical and unacceptable.

After manuscript submission, no authorship changes (including the authorship list, author order, and who is designated as the corresponding author) should be made unless there is a substantive reason to do so. The editor and all co-authors must agree on the change(s), and neither the Journal nor the publisher mediates authorship disputes. If individuals cannot agree on the authorship of a submitted manuscript, contact the editorial office at [email protected]. The dispute must be resolved among the individuals and their institution(s) before the manuscript can be accepted for publication. If an authorship dispute or change arises after a paper is accepted, contact OUP’s Author Support team. COPE provides guidance for authors on resolving authorship disputes. 

For more information about authorship, see the ICJME guidelines.

Contributors 

Any other individual contributor or group of contributors to the work who do not qualify for authorship but who meet some of the four ICMJE criteria listed above should be listed in the article in a section under the heading “Acknowledgements”. As per the ICJME guidelines, the contribution of each individual or group must be specified. For more information, refer to section 3 of the ICJME guidelines.

Disclosure of Interest 

All authors must declare any conflicts of interest. It is the responsibility of the submitting author to ascertain any conflicts of interest from co-authors and declare these at the point of submission. Any potential conflict of interest that might constitute an embarrassment to any of the authors if it were not to be declared and were to emerge after publication should be declared.

A detailed definition of conflicts of interests

Instructions for the corresponding author:

• Submit an International Committee of Medical Journal Editors (ICJME) disclosure of potential conflicts of interest (COI) form for each author by revision stage at the latest.
• When the form is uploaded to Editorial Manager, include the author’s last name in the document title of the form.
• A form must be submitted even if there are no conflicts of interest to declare, in which case the conflict of interest form should state “none declared”.
• Submit a concise and accurate summary of any conflicts of interest declared in the ICMJE forms in a separate document under the “Disclosures” header. If there are no conflicts of interest, state “Conflict of interest: none declared”. The text under “Disclosures” will be included at the end of the article when published.

Misconduct

COPE defines plagiarism as “when somebody presents the work of others (data, words or theories) as if they were their own and without proper acknowledgment.”

COPE defines redundant/overlapping publication as “when a published work (or substantial sections from a published work) is/are published more than once (in the same or another language) without adequate acknowledgment of the source/cross-referencing/justification; or, when the same (or substantially overlapping) data is presented in more than one publication without adequate cross-referencing/justification, particularly when this is done in such a way that reviewers/readers are unlikely to realise that most or all the findings have been published before.”

COPE defines citation manipulation as “behaviours intended to inflate citation counts for personal gain, such as: excessive self-citation of an authors’ own work, excessive citation to the journal publishing the citing article, and excessive citation between journals in a coordinated manner.”

Data fabrication is defined as intentionally creating fake data or misrepresenting research results. An example includes completely inventing data sets.

Data falsification is defined as manipulating research data with the purpose of intentionally giving a false representation. This can apply to images, research materials, equipment, or processes. Examples include cropping of gels/images to change context and omission of selected data.

If notified of a potential case of research misconduct or breach of publication ethics, the Journal editor and editorial office staff may inform OUP and/or the author’s institutional affiliation(s).

Informed Patient Consent

Authors should observe high standards with respect to publication ethics as set out by the Committee on Publication Ethics (COPE) and International Committee of Medical Journal Editors (ICMJE) recommendations for reporting about patients. Patients have a right to privacy that should not be infringed without prior informed consent.

Identifying information should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) has given written informed consent for publication. Informed consent for this purpose requires the patient be shown the manuscript to be published.

Identifying details should be omitted if they are not essential, but patient data should never be altered or falsified to attain anonymity. We understand that complete anonymity is difficult to achieve. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.

The Supplement requires at the point of submission that a consent form has been completed for any manuscripts in which an individual or a group of individuals can be identified. A statement addressing informed patient consent must be included as part of the manuscript under the heading “Consent”. If the patient or relatives of a deceased patient cannot be traced and consent cannot be obtained, the case or data can only be considered for publication if it is sufficiently de-identified.

Completed consent forms are not to be submitted to the Supplement. Completed forms should be held by the treating institution according to locally approved procedures. The consent form should be made available to the Supplement Editor if specifically requested.

The Editorial Board reserves the right to reject papers for which the ethical aspects are, in the Board’s opinion, open to doubt. Please contact the Editorial Office if you have any queries regarding consent.

Ethics

In addition to the below, authors should refer to the EQUATOR Network for guidance on study ethics and reporting.

Reporting Demographic Information for Study Participants

The Supplement adopts the definitions of sex and gender proposed by the Institute of Medicine Report, the United States National Institutes of Health, and the Canadian Institutes of Heart Research.

De-identified information on demographics (e.g., age, sex, race/ethnicity, and/or socioeconomic indicators) should be described where available. This information should be included in the methods and/or results section of the article. Authors are required to explain demographic variables that have been collected but which are not included in the manuscript.

Terms and recommendations:

Sex and gender stratified data should be uniformly provided (in the work when relevant, in the Appendix when not). Authors should refer to the Sex and Gender Equity in Research (SAGER) guidelines.

Lack of compliance will not prevent the publication of the manuscript, but it will be disclosed in the same way as conflict of interest disclosures.

Statistics

The application of adequate statistical methods is required for publication in European Heart Journal Supplements. The Supplement advises authors to be as simple as possible, but as sophisticated as needed. For example, clinical trials with their formalised framework must meet more specific statistical standards than pathophysiological studies. Authors are advised to include absolute risk as well as relative risk where possible. For studies with a sophisticated design, the collaboration of a professional statistician is recommended.

Authors should refer to the following guidance before submitting:

• ‘Statistical Analysis’ in the European Heart Journal Quality Standards document
• A detailed summary of relevant points regarding study design, analysis, and reporting 

Data Policy 

Where ethically feasible, the European Heart Journal Supplements strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers.

We suggest that data be presented in the main manuscript or additional supporting files or deposited in a public repository whenever possible. Information on general repositories for all data types, and a list of recommended repositories by subject area

In support of our policy, authors of original articles, reviews, and short reports are required to include a Data Availability Statement in their paper, even if no data are presented or discussed. Data Availability Statements provide a standardised format for readers to understand the availability of data underlying the research results described in the article. The statement may refer to original data generated in the course of the study or to third-party data analysed in the article. The statement should describe and provide means of access, where possible, by linking to the data or providing the required unique identifier. If no data is presented or discussed in your paper, you should indicate this as follows (or similar): “No new data were generated or analysed in support of this research”.

More information and example statements

Authors may be asked to make available the underlying deidentified data on which their research relies to the Supplement for inspection and verification during the peer review process.

Data Citation 

The Supplement supports the Force 11 Data Citation Principles and requires that all publicly available datasets be fully referenced in the reference list with an accession number or unique identifier such as a digital object identifier (DOI). Data citations should include the minimum information recommended by DataCite:

               [dataset] Authors, Year, Title, Publisher (repository or archive name), Identifier

Authors should include the dataset tag – [dataset] – at the beginning of the citation. This helps the Publisher correctly identify and tag the citation. The tag will be removed from the citation published in the reference list.

Peer Review Policy 

European Heart Journal Supplements only considers invited manuscripts. All manuscripts are initially screened by the Editor-in-Chief. At this stage, the manuscript may be returned to the authors without peer review if it is felt that the paper does not meet the submission requirements.

Manuscripts that pass initial assessment will undergo appropriate single-anonymised peer review by at least two reviewers. Single-anonymised peer review means that the identities of the authors are known to the reviewers, but the identities of the reviewers are not known to the authors.

European Heart Journal Supplements publishes conference abstract supplements that are peer reviewed by the conference organisers, rather than the journal.

Appealing a Decision

If the authors have reason to believe that the review process or final decision has not been fair or well-informed, the authors may submit an appeal to the Supplement. Appeals can be submitted within one month of the final decision on the manuscript. Only one appeal per manuscript will be considered. The appeal will be considered carefully by the Editor-in-Chief and the Editorial Board.

Appeals should be submitted via email to [email protected]. The appeal should include:

• Names of all authors submitting the appeal
• Email addresses and contact details of the authors, or the corresponding author
• Full manuscript title
• Manuscript ID from Editorial Manager
• An explanation outlining why the final decision was unfair or not merited
• Specific comments in relation to the peer review reports

Preprints and self-archiving

Authors retain the right to make an Author’s Original Version (the draft before submission and peer review, also called the “preprint”) available through various channels and this does not prevent consideration by the Supplement. At initial submission, authors should indicate if any preprint is available in a server or repository. If accepted, the authors are required to update the status of any preprint, including adding the published paper’s DOI. More information on allowed channels and updating your preprint

Authors of all article types, excluding ESC Guidelines, may enter their Accepted Manuscript (the final draft after peer review but before copyediting, typesetting and proof correction, also called the “post-print”) in PubMed Central, other subject repositories, or institutional repositories providing that the public availability of the manuscript is delayed by 12 months after the first online publication.

Preparing your manuscript

Pre-submission Language Editing
Style
Abbreviations
General Formatting
Title Page
Text Abstract
Graphical Abstract
Keywords
Tables
Figures
Videos
Acknowledgements
Funding
References
Supplementary Material
Third Party Permissions

Pre-submission Language Editing 

Authors may choose to use a language-editing service before submitting to the Supplement.

Style

Oxford English spelling should be used throughout, except in quotations and in references.

Abbreviations 

SI units of measurements should be used. Authors should define nonstandard abbreviations when they first appear in the manuscript.

General Formatting

Authors should follow the general guidance below:

• Prepare the manuscript using a Word processing package (save in .doc format)
• Use double-spaced throughout the manuscript
• Number each page consecutively
• Include line numbers on all pages. Line numbers should restart on each page.
• Avoid using footnotes; use parentheses within brackets
• Type references in the correct order and style of the Supplement (see References below)
• Type unjustified
• Do not use hyphenation except for compound words or terms
• Use the TAB key once to indent paragraphs
• Clearly identify uncommon symbols and any Greek letters
• Use formatting in Word to indicate bold, italic, Greek, mathematics, superscript, and subscript characters
• Indicate the approximate position of each figure and table
• Write out numbers one to ten in full (e.g., ‘one’ not ‘1’) unless they are used as a unit of measurement or describe a figure, table, or video (e.g., Figure 1)

Title Page

The title page should include:

• the title of your paper
• all author names and affiliations
• the institution where the work was performed
• the mailing address and email address of one corresponding author
• the wordcount of the manuscript excluding the title page, abstract(s), and references

An effective title describes the content and main messages of the manuscript clearly and succinctly. In general, article titles should:

• be as short as possible
• include the most important keywords at the beginning
• avoid abbreviations or acronyms, unless the title will be very long without them

Text Abstract

Text Abstracts should not exceed 250 words and should not contain references.

Graphical Abstract

Authors may choose to submit a graphical abstract with their manuscript. The graphical abstract should provide a visual summary of the main messages (take-home messages) of the paper.

• Size: 11.00 cm x 18.0 cm (height x width)
• Minimum resolution: 300 ppi (the ppi of an image can usually be found by right-clicking on an image file and selecting ‘Properties’)
• Font: use a sans serif font. Gill Sans is preferred but Myriad Pro, Arial, or Helvetica are acceptable.
• Font size: text should be 10-12 points, but no smaller than 8 points
• If the quality is not sufficient the Editorial Office may contact the authors to provide a replacement graphic

Keywords 

Authors should provide up to six keywords with the manuscript.

Tables 

Formatting guidelines:

• It is preferable to provide tables in portrait layout with no more than 9 columns
• Centre each column around its header
• Avoid using colour and shading, as these are not used when published
• All tables should be numbered (e.g., Table 1) and referenced in the text
• Tables should have a description, title, or legend
• Tables should not be split into parts (e.g., Table 1a, 1b etc.)

Submission guidelines:

• Tables and their legends should be included in the manuscript file at the end of the document
• Tables should be in an editable format and should not embedded as an image file
• Legends for tables should define all symbols and abbreviations used in the table. Common abbreviations and other in the preceding text should be not redefined in the legend.

Please note that additional tables may be submitted as supplementary online-only material.

Figures

Figures should be limited to the number necessary for clarity and must not duplicate data from the tables or the text.

Additional figures may be submitted as supplementary online-only material.

General guidance for all figure types:

• Each figure should be provided as an individual image file.
• Each figure should be numbered consecutively (e.g., Figure 1, Figure 2) and referenced in the text.
• Text in figures should use a sans serif font. Gill Sans is preferred but Myriad Pro, Arial, or Helvetica are acceptable.
• Note that the use of red and green in figures may cause difficulty for individuals with colour-blindness.
• Legends for figures should be included in a separate section of the manuscript grouped under the heading ‘Legends’, after the ‘References’ section. Define all symbols and abbreviations used in the figure. Common abbreviations and other in the preceding text should be not redefined in the legend.
• Figures should not be submitted if the copyright of the figure is unclear (e.g., images downloaded from the internet). Permission must be sought and granted for all figures being reproduced in the Supplement, and correct attribution must be given in accordance with the licence of the original work.
• European Heart Journal Supplements does not charge for colour figures of any type.
• Guidance on file type, resolution, and quality for each type of figure is given below.

Photographs and Images:

Photographs and images should be provided as raster images. Common examples of raster images are .tif/.tiff or .raw file types. The resolution of raster files is measured by the number of dots or pixels in a given area, referred to as “dpi” or “ppi”. This information is given in the image properties, which can usually be found by right-clicking on an image file and selecting ‘Properties’. Dpi and pixel width are included in the ‘Details’ tab.

• Minimum resolution: 350 dpi
• Recommended resolution: 600 dpi
• Photographs and images need to be of high enough quality to withstand the loss of contrast and detail when printed. It is not possible to improve the quality of an image during the production process. Before submitting a photograph or image check that details are clear, that contrast is good, and that there is low noise.

Line art:

Line art images should be provided as raster images. Common examples of raster images are .tif/.tiff or .raw file types. The resolution of raster files is measured by the number of dots or pixels in a given area, referred to as “dpi” or “ppi”. This information is given in the image properties, which can usually be found by right-clicking on an image file and selecting ‘Properties’. Dpi and pixel width are included in the ‘Details’ tab.

• Minimum resolution: 600 dpi
• Recommended resolution: 1200 dpi
• Colour: use CMYK or RGB format.
• Size: submit the line art in the size intended for publication in print
• Font: use a sans serif font. Gill Sans is preferred but Myriad Pro, Arial, or Helvetica are acceptable.
• Font size: no smaller than 2mm in height.
• If stippling is used, use clear black dots with visible white space between them. Faint and grey stippling will be lost during production and should be avoided.
• Ensure that it is easy to differentiate between different levels or types of shading.

Charts, graphs, and diagrams:

Charts, graphs, and diagrams are best rendered digitally as geometric forms called vector graphics. Common file types are .eps, .svg, .ai, and .pdf. Vector images use mathematical relationships between points and the lines connecting them to describe an image. These file types do not use pixels, which means that resolution does not apply to vector images.

• It is preferable to use colour in charts, graphs, and diagrams rather than black and white or grayscale. Avoid pale colours and colour combinations that may be difficult for colour-blind readers.
• Ensure that it is easy to differentiate between different levels or types of shading.
• Colour should be submitted in CMYK or RGB format.
• Ensure that the axes are easy to read (i.e., clear tick marks and axes labels).
• Elements within diagrams should be clearly labelled and formatted consistently.

Multipanel figures:

Submit all panels of a multipanel figure as a single file in Editorial Manager.

Each panel should be labelled with a letter (e.g., A, B, C) in the upper-left corner. It is recommended that a multipanel figure does not contain more than six panels.

Preparation guidance:

• Each panel of the multipanel figure should follow the guidance relevant to the figure type, given above. For example, a graph should refer to the guidance above for charts, graphs, and diagrams.
• Dedicated software should be used to combine the panels into a single figure, such as Photoshop, GIMP, Illustrator, or InkScape. We do not recommend using PowerPoint.

Figure accessibility and alt text

Incorporating alt text (alternative text) when submitting your paper helps to foster inclusivity and accessibility. Good alt text ensures that individuals with visual impairments or those using screen readers can comprehend the content and context of your figures. The aim of alt text is to provide concise and informative descriptions of your figure so that all readers have access to the same level of information and understanding, and that all can engage with and benefit from the visual elements integral to scholarly content. Including alt text demonstrates a commitment to accessibility and enhances the overall impact and reach of your work.  

Alt text is applicable to all images, figures, illustrations, and photographs. 

Alt text is only accessible via e-reader and so it won’t appear as part of the typeset article. 

Detailed guidance on how to draft and submit alt text. 

Videos 

Formatting guidelines:

• Format: .mp4 or .avi format only
• Videos should be numbered consecutively (e.g., Video 1, Video 2) and referenced in the text.
• Authors should provide a still image for each video, which will be used in the PDF version of the article. The video still should be provided in .eps, .svg, .ai, or .pdf format. Each video still should be clearly numbered (e.g., Video 1 still image, Video 2 still image).
• Please note that the Supplement cannot use videos hosted on third-party sites such as YouTube, as the link may expire.

Submission guidelines:

• Upload each video and video still image as a separate file under the header “Video” in Editorial Manager.
• Legends for videos should be included in a separate section under the heading ‘Legends’, after the ‘References’ section of the manuscript. Define all symbols and abbreviation used in the video. Common abbreviations and other in the preceding text should be not redefined in the legend.
• Videos should not be submitted if the copyright of the video is unclear (e.g., a video downloaded from the internet). Permission must be sought and granted for all videos being reproduced in the Supplement, and correct attribution must be given in accordance with the licence of the original work.

Additional videos may be submitted as supplementary online-only material.

Acknowledgements 

Substantive contributions of individuals should be noted in an “Acknowledgements” section, above the “Conflict of Interest” section. This section can include individuals who do not meet the ICMJE criteria for authorship, but nevertheless were contributors to the paper. See the Authorship and Contributors sections above.

Funding 

Details of all funding sources for the work should be given in a separate section entitled “Funding”.

The following rules should be followed:

• Funding agency names should be given in full without abbreviations: e.g., National Cancer Institute at the National Institutes of Health
• Grant numbers should be complete and accurate and provided in brackets: e.g., (grant number ABX CDXXXXXX)
• Multiple grant numbers should be separated by a comma: e.g. (grant numbers ABX CDXXXXXX, EFXXXXXX)
• Agencies should be separated by a semi-colon (plus ‘and’ before the last funding agency)
• Where individuals must be specified for certain sources of funding, the following text should be added after the relevant agency or grant number 'to [author initials]'.

Funding statement examples:

• Wellcome Trust (grant numbers AA-10101, BB949/2-3) to M.H. and P.P.F. Funding for open access charge: Wellcome Trust (grant number CB5453961-7).
• National Cancer Institute at the National Institutes of Health (grant number L-130-A); National Heart, Lung, and Blood Institute at the National Institutes of Health (grant number A-158912/1); and National Institute of Nursing Research at the National Institutes of Health (grant numbers W-1120, G-819-1).

References

References should be identified in the text by Arabic numerals and numbered in the order cited. All references should be compiled at the end of the article in Vancouver style (i.e., author-number system). Complete information should be given for each reference, including the title of the article, abbreviated journal title, and page numbers. If there are more than six authors, the first six authors should be listed followed by ‘et al.’.

Personal communications, manuscripts in preparation, and other unpublished data should not be cited in the reference list but may be mentioned in parentheses in the text. Authors should obtain permission from the source to cite unpublished data. Titles of journals should be abbreviated in accordance with MEDLINE. If a journal is not listed in MEDLINE, the journal name should be written out in full.

Article citation examples:

• Peters S, Reinders B. Cardiovascular Diseases. Journal Abbrev 2022;1:100–116. doi: https://doi.org/10.1093/journal/abc123
• Barbosa SA, Kulikova B, Lund R, Kowalska G, Burtole J, Ivanković SL, et al. Cardiovascular Diseases. J Abbrev 2022;10:15–20. doi: https://doi.org/10.1093/journal/def456

Book citation example:

• Nicholaus S, Ralla DE Jr. Cardiovascular Diseases. 4th ed. London: Publisher; 2021. p120-206.

Chapter citation example:

• Ryan D, Witteland AWR. Heart Failure. In: Nicholas S, Raffa DE. Cardiovascular Diseases. 4th ed. London: Publisher; 2021. p157–158.

Conference proceedings example:

• Brooks AD. Cardiology. In: Abstracts of the Annual Conference, Paris, France, 2022. Abstract A-2239, p671. International Society, Paris, France.

Webpage citation example:

• Cardiology Society. Cardiovascular Diseases: Summary. Available from: http://www. website.org (accessed 1 Jan 2022).

Preprint article citation example:

• Olsen T, Hughes C, Holmberg LB. Cardiovascular Diseases. BioRxiv [Preprint] 2022. Available from doi.org/10.0000/123456.

Supplementary Material 

Authors must submit all supplementary material at the same time as the manuscript to be peer reviewed. The following guidance should be followed:

• All supplementary material must be clearly labelled (e.g., Supplementary Figure 1, Supplementary Video 1 etc.)
• Supplementary material must be cited in the text of the main manuscript
• Style and formatting of supplementary material should be consistent with that of the manuscript and should be formatted to function on any internet browser. However, supplementary material will not be copyedited or typeset and will be published online in the format provided during submission.
• The material should be uploaded in a non-editable format where possible
• It is not necessary to include the study protocol, but this could be referenced in the text if it is available online

Third Party Permissions 

Authors must obtain permission for any material being reproduced – including quotations, images, tables, or videos – for which they are not the copyright holder. Permissions should be sought from the original copyright holder.

If the supplement will be published open access, but the manuscript to be published contains material for which the authors do not have open access re-use permissions, the following credit line should be included with the material:

• Title of content
• Author, Original publication, year of original publication, by permission of [rights holder]
• This image/content is not covered by the terms of the Creative Commons licence of this publication. For permission to reuse, please contact the rights holder.

Further information on obtaining permissions

All permissions letters should be included with the original submission via Editorial Manager.

If the manuscript does not contain any reproduced material, authors should upload a word document under the head ‘Permissions’ in Editorial Manager, with the following statement: “The authors do hereby declare that all illustrations and figures in the manuscript are original and not require reprint permission”.

How to submit 

Authors should submit their manuscript through Editorial Manager. If the corresponding author has not previously submitted to the Supplement, they will need to register for an account. 

At initial submission authors are required to:

• Select the supplement to which you have been invited to submit from the drop-down menu
• Answer all questions in the online submission form
• Submit all parts of the manuscript, including the abstract, figures, figure legends, and supplementary files 

The corresponding author is responsible for providing the full list of co-authors on the manuscript. The co-authors will receive an email asking them to verify their contribution to the manuscript. The corresponding author is responsible for ensuring that this step is completed.

Questions about the submission process can be sent to the Editorial Office at [email protected].

Production of your manuscript

Proofs
Post-publication Corrections
Retractions

Proofs 

Page proofs will be submitted to the corresponding author electronically. These should be checked thoroughly for any changes or typographic errors.

It is the Publisher’s intent to review and correct the proofs and publish the accepted work as soon as possible. To achieve this, all corrections must be returned to the Publisher within 3 days.

Post-publication Corrections 

The Publisher will only make changes to published papers if the publication record is seriously affected by the academic accuracy of the published information.

Changes to published papers are accompanied by a formal correction notice. The notice will be published online at the earliest opportunity and will link to the paper being corrected. A link will also appear on the paper being corrected, notifying readers that a correction has been published.

Changes cannot be made to papers that have been published online for more than 12 months. In such instances a correction will be published explaining the error, but the paper will not be updated. The correction will be published online with links to the original paper as described above.

Corrections to abstract supplements are made only in exceptional circumstances.

To submit a correction the corresponding author should email [email protected].

Read OUP’s full corrections policy

Retractions 

The Supplement subscribes to the COPE Retraction Guidelines, which outlines appropriate use cases for retractions.

Contact us 

For any questions or feedback please contact [email protected].